• Loading stock data...
PublicWire | Emerging Market Stock News
  •  Home
  • Technology
  • Medical
  • Energy
  • Cannabis
  • Finance
  • Retail
  • General
  • Podcast
  • Videos
  • Services
  •  Home
  • Technology
  • Medical
  • Energy
  • Cannabis
  • Finance
  • Retail
  • General
  • Podcast
  • Videos
  • Services
No Result
View All Result
PublicWire
No Result
View All Result

Home » Medical » Cannabis Watch: Aurora Cannabis leads sector after stock is named Top Pick at Cowen

Cannabis Watch: Aurora Cannabis leads sector after stock is named Top Pick at Cowen

Anthony Ramsumiran by Anthony Ramsumiran
April 26, 2019
in Medical
5 min read
69
0
Cannabis Watch: Aurora Cannabis leads sector after stock is named Top Pick at Cowen

Cannabis shares were mostly higher Tuesday, with Aurora Cannabis Inc. a standout, after Cowen designated the stock its Top Pick in the sector, citing growth opportunities in the Canadian legal recreational market and burgeoning international medical market.

Aurora stock

ACB, -5.64%

ACB, -5.32%

 rose 9%, after Cowen assigned it an outperform rating and C$14 price target ($10.50), equal to 46% above its current trading level.

“The company’s large cultivation footprint, capable of producing over 575,000 kg, provides ACB with the necessary infrastructure to weather early storms in adult use while continuing to grow higher-value revenues in the medical market,” analysts led by Vivien Azer wrote in a note.

Cowen is expecting the Canadian recreational and medical markets to represent a total addressable market of about C$12 billion by 2025. It expects the international medical market to grow to $31 billion by 2024, up from a previous estimate of just $9 billion.

See also: Canada’s black market for cannabis remained strong in fourth quarter

Aurora’s presence in 23 international markets should boost its ability to capture global market share, said the note. Cowen is expecting Aurora to generate revenue of C$305 million in fiscal 2019, rising to C$742 million by fiscal 2020 and to C$1.34 billion by fiscal 2022.

Cronos Group Inc.

CRON, -6.38%

 shares reversed early losses to trade up 7.6%, after Cowen initiated coverage of that stock with a market perform rating and C$29 price target, that is just above its current price of C$28.56.

Don’t miss: How the unsteady rise of the pot industry has made dime bags a billion-dollar business

Also: How marijuana companies can profit without selling pot

“We like CRON’s story as an asset-light, global low-cost producer with operational support and significant invested capital from Altria Inc.,” Azer wrote in a note. “However, valuation prevents us from taking a more constructive position at this time.”

Also Tuesday, medical cannabis information website Leafly said a data team working with Whitney Economics estimates that legal cannabis has created more than 211,000 jobs across the U.S., about 64,000 of which were added in 2018.

The cannabis workforce rose 21% in 2018 and 44% in 2018, according to their research and is expected to climb at least another 20% in 2019. Because of the continued federal ban on cannabis, the U.S. government does not officially count cannabis jobs, nor are they included in official statistics or economic reports.

In Colorado, a House panel advanced a bill that aims to open the state’s $1.4 billion-a-year recreational and medical market to new sources of public and private capital, as MJBizdaily.com reported.

“The lack of investment opportunity is the single-biggest burden we have,” Shannon Fender, director of public affairs of Native Roots, one of Colorado’s largest marijuana operators, told the committee’s public hearing.

See also: Washington moves closer to delivering protections for banks that work with the pot industry

MedMen Enterprises Inc.

MMNFF, +4.41%

 was down 2.2%, after the company acknowledged that it had engaged a firm called Wining Media LLC to provide public relations and communications for the company, that included promoting its stock through ads on Google and Yahoo Finance, along with an article on a website called marijuanastox.com. The company’s former finance head alleged in a lawsuit that it had hired a consultant to prop up the stock, a claim the company initially dismissed as baseless.

For more, see: MedMen cuts fundraising round nearly in half, as CFO quits

But MedMen said late Monday that after receiving inquiries from OTC Markets Group, it looked into the matter and discovered Wining did use statements that “encourage investors to purchase the stock of the company.”

“The company has concluded, upon investigation, that, in this instance the article was not approved according to the company’s internal procedures,” it said in a statement.

MedMen “disclaims any potentially exaggerated or misleading statements contained in the materials,” and has instructed Wining to remove all promotional materials from the public domain and to cease all promotional efforts on its behalf. It acknowledged that it has hired five separate companies to provide investor relations, PR services and marketing including the promotion of its securities in the past year.

Elsewhere in the sector, Tilray Inc.

TLRY, -4.40%

 was up 0.4%, Hexo Corp.

HEXO, -6.19%

was down 0.8% and Aleafia health Inc.

ALEF, -0.44%

ALEF, -0.44%

was up 6%. OrganiGram Holdings Inc.

OGRMF, -2.41%

was up 2.8%, CannTrust Holdings Inc.

CTST, -3.31%

TRST, -3.01%

 was up 1.5%.

GW Pharmaceuticals PLC

GWPH, -4.07%

 was flat and Green Growth Brands Inc.

GGBXF, -2.02%

 was down 0.8%.

See: People in states where marijuana is legal are eating more cookies and ice cream

The Horizons Marijuana Life Sciences ETF

HMMJ, -3.42%

was up 3% and the ETFMG Alternative Harvest ETF

MJ, -4.19%

was up 1.9%.

The S&P 500

SPX, -1.90%

and the Dow Jones Industrial Average

DJIA, -1.77%

were flat.

For all of MarketWatch’s coverage of cannabis companies, click here.

Read More

Anthony Ramsumiran

Anthony Ramsumiran

Anthony has a very strong background in Economics. He was born and raised in London and is now based in Orlando, Florida. With over 17 years of experience in automotive and technology.

Related Posts

Regeneron buy back shares from Sanofi
Medical

Regeneron to buy back $5 billion shares from Sanofi

May 25, 2020
137
A report reveals that China is deliberately faking the number of COVID-19 cases and deaths.
General

China is underreporting COVID-19 cases, U.S. intelligence community says

April 1, 2020
152
Around the world, the total number of confirmed coronavirus infection went beyond 600,000, with 28,964 fatalities as of the latest report.
Medical

17% of all confirmed COVID-19 cases in the world comes from the US

March 28, 2020
139
President Donald Trump signed a $2 trillion coronavirus relief bill on Friday
General

Trump signs $2 trillion coronavirus relief

March 28, 2020
121
General Motors and Ventec Life Systems are partnering to convert the GM Kokomo, Indiana ERC building for the production of Ventec ventilators in response to the COVID-19 pandemic.
General

GM announces the start of production of critical-care ventilators shortly after Trump’s tweets against CEO

March 27, 2020
135
Rep. Thomas Massie, R-Ky., tried to force a full yes or no vote on the measure, which could have delayed its passage by hours.
Finance

$2 trillion coronavirus stimulus package passed by the House amid efforts to delay voting by Massie

March 27, 2020
123
Currently Playing

Subscribe To Our Newsletter

Ad

PublicWire | Emerging Market Stock News 24/7 | Investor Relations US Stock Market

© Copyright 2020 PublicWire.com

Navigate Site

  • About
  • #96576 (no title)
  • Disclaimer
  • Watch LIVE
  • Privacy Policy
  • Terms and Services
  • Contributors

Follow Us

No Result
View All Result
  • LIVE Investor News Channel
  • Cannabis
  • Energy
  • Finance
  • General
  • Medical
  • Podcasts
  • Retail
  • Technology
  • #370 (no title)

© Copyright 2020 PublicWire.com

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Public Wire Logo

Hello please subscribe to our newsletter to get up to date news weekly!

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.